Profile
ARTL VRTX REGN SGEN ALNY ARGX
Company Name Artelo Biosciences, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.32M $116.96B $55.30B $43.15B $41.50B $33.66B
Employees 0.01K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Gregory D. Gorgas M.B.A. Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ARTL VRTX REGN SGEN ALNY ARGX
Quant Rating Score 3 2 4 3 1 1
Quant Rating Neutral Sell Buy Neutral Strong Sell Strong Sell
Trading
ARTL VRTX REGN SGEN ALNY ARGX
Last Close $6.79 $441.3 $521 $228.74 $322.83 $560.14
High 52 $7.2 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $0.82 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -5.69 % -14.6 % -56.65 % 0 % -0.67 % -16.61 %
Price vs. 52 Week Low 728.05 % 11.26 % 7.89 % 0 % 43.75 % 30.25 %
Total Return
ARTL VRTX REGN SGEN ALNY ARGX
1 Month Return 546.67 % -0.17 % 6.27 % 0 % 6.02 % -2.29 %
3 Month Return 622.34 % -10.43 % -18.26 % 0 % 20.25 % -4.92 %
6 Month Return 546.67 % 10.5 % -25.85 % 0 % 36.79 % -9.65 %
9 Month Return 506.14 % -5.11 % -50.44 % 0 % 17.38 % 3.33 %
YTD Return 540.57 % 9.59 % -26.86 % 0 % 37.19 % -8.92 %
1 Year Return 406.72 % -5.85 % -50.43 % 0 % 32.85 % 30.25 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARTL VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ARTL VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -48.35 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -62.8 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -52.95 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 97.93 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 98.02 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -12711.11 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -16.97 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -16.97 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 3714.63 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -12711.11 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.41 -92.97 18.31 -81.26 -550.45 -433.65
Price To Operating Cash Flows Ratio TTM -0.36 -119.36 14.06 -93.1 -914.84 -515.25
Price Cash Flow Ratio TTM -0.36 -119.36 14.06 -93.1 -914.84 -515.25
Income Statement (TTM)
ARTL VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -3.49 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ARTL VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.01B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.02B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ARTL VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.22
AARD Aardvark Therapeutics, Inc. Common Stock 13.5
ABCL AbCellera Biologics Inc. 3.42
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.69
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.165
ABPWW 0.0207
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.08
ABVC ABVC BioPharma, Inc. 2.225
ABVX Abivax SA American Depositary Shares 7.665
ACAD ACADIA Pharmaceuticals Inc. 21.58
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6143
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.25
ACIU AC Immune SA 2.02
Unlock